Imperial acquires D. Anderson & Company; expands clinical trial services
Michigan, US-based clinical research organisation (CRO), Imperial, has completed the acquisition of clinical trial specialists, D. Anderson & Company for an undisclosed fee.
Archives for April 3, 2011
BASF raises all API and excipient prices 10%
Chemicals supplier BASF has increased the price of all APIs and drug excipients by 10 per cent, citing higher costs
Comprehensive Clinical Development finalises deal for Charles River
Comprehensive Clinical Development, a contract research organisation based in Florida, US, has finalised the acquisition of clinical trials specialist, Charles River Clinical Services.
Pharma future bright for Puerto Rico says PRIDCO
The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial Development Company (PRIDCO).
Chiltern expands European operations; opens new Netherlands office
Chiltern International, a global contract research organisation (CRO) has expanded its European operations with the opening of a new office in the Netherlands.
China’s booming pharma sector welcomes western investors
Double-digit growth in the Chinese pharmaceutical sector will increasingly make the nation a lucrative place for Western companies to do business, delegates heard at the InterPhex trade event in New York.
ATMI unveils helium integrity testing for bioprocess vessels at Interphex 2011
ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level.